Four investigators have shown in experimental animals that maternal age influences cancer susceptibility in the offspring. These are Bittner, working with adenocarcinoma of the mammary gland, MacDowell and Law investigating leukemia, and Strong with chemically induced fibrosarcoma. These studies have all been done on mice and all three tumors are apparently biologically different.' Longevity in man is influenced by (i) maternal age at the time the child was born (Jalavisto), (ii) the number of children in the family (Beeton, Yule, and Pearson), (iii) the decrease of infant mortality with advancing age of parents (Ploetz), (iv) the age at death of the parents (Jalavisto and Ploetz), and probably by many other factors which are yet unknown. A complete bibliography and a summary showing the present status of the problem of parental age is being published as a monograph on Parental age and characteristics of the offspring by the New York Academy of Sciences.
The experimental work on chemically induced fibrosarcomas in mice' has shown that the ordinal sequence of litters influences fibrosarcoma susceptibility, obviously a reflection of maternal, if not parental, age,* and that the size of the family determines trends in cancer susceptibility.
A summary of research, upon which the first statement above is based, is as follows: The present study deals with the appearance of fibrosarcomas in mice following the subcutaneous injection of methylcholanthrene at sixty days of life. For this purpose, 1,806 mice have been used, of which 1,115 were females and 691 males. The mice belonged to one original inbred strain of 30 generations which was continued by brother to sister matings exclusively. Three sublines have been continued: the original inbred, and two selected descents from parents belonging to first or second litters (early litter descent) or the 7, 8, or 9th litters (advanced litter descent). Divergence in the appearance of fibrosarcomas has been obtained in the two selected descents which amount to 28.0 ± 2.64 days. This difference is 10.6 X P.E. The evidence thus demonstrates that the principle as measured by litter seriation (ordinal sequence of the family) which affects chemically induced fibrosarcomas in the offspring is cumulative. A selection toward the suppression of the size of the family increased susceptibility (as measured by latent period or time between the injection of methylcholanthrene and the appearance of tumors) to chemically induced fibrosarcomas. The second conclusion above is based upon the following observations. A total of 1,309 mice of four inbred descents, Prunt, 2Prunt, Pridil, and Survey of human cancer based upon parental age I STRONG IpBr have been injected with 1 mg. of methylcholanthrene dissolved in 0.1 cc. of sesame oil at 60 days of age; they developed fibrosarcomas at the site of injection and died. The mice belonged to the 1 to 12 litters. The characteristics of (i) latent period for the appearance of tumors, (ii) survival time with growth of tumors, (iii) age at death, (iv) a sex differential, and (v) invasiveness or ability to invade into the abdomen are analyzed in terms of litter seriation. A brief review of the literature is given and the problem of tissue specificity is cited.
Mice in successive litters show differences in susceptibility to chemically induced fibrosarcomas (latent period) and in characteristics of malignancy (survival time and invasiveness). There seems to be an inverse relation between survival time and latent period, although two mechanisms appear to be evident. In the Prunt strain female mice develop tumors earlier in succeeding litters, even though the males do not do so, thus bringing about a sex differential in relation to fibrosarcomas which increases in successive litters. Female mice show more tumors with the ability to invade into the abdomen than do males. The number of mice with malignant tumors (invasiveness) is reduced in mice of both sexes in successive litters. Survival time is also influenced by litter seriation.
The present data indicate two hereditary mechanisms involved in cancer susceptibility and malignancy which change during the life span of a female mouse and are handed down to her progeny. This transmission is apparently not by way of the chromosomes or genes but may involve cytoplasmic inheritance.
Literature on the size of family in man (except to show that it is getting progressively smaller in the United States), on either longevity or cancer susceptibility is not available. The age of the parents at the time of the birth of the offspring has not been adequately investigated in man either as a possible cause of increased expectancy of life or of alterations in cancer susceptibility.
It is proposed now by a group of investigators representing the various biological fields, such as genetics, gerontology, medicine, public health, etc., to pursue the following program on human subjects.
1. Ascertain data on parental (particularly maternal) age at birth of cancer proband, and to compare these data with a similar group of controls (non-cancer) of approximately the same age and circumstances.
2. Determine the ordinal sequence of the family for cancer patients and their controls.
3. Ascertain data on vital statistics for older and younger brothers and sisters to cancer patients and their controls.
Since the size of the American family is becoming smaller (4.9 in 1890 to 3.56 in 1950) , the present survey should be of a preliminary nature because most people at present belong to small families. The final evaluation should be placed on the complete analysis of the large family.
This preliminary program should indicate (i) where cancer has occurred in a large family, (ii) the most likely types of human cancer that should be more carefully investigated, (iii) the causes of death of brothers and sisters of cancer patients and their controls, and (iv) whether the differences in cancer susceptibility between children of subsequent births are great enough to warrant a more extended investigation over a period of years of the possible cumulative effect of maternal age or restriction of the size of the family on cancer in the human offspring.
